Triamcinolone Nasal

In the U.S.

• Nasacort
• Nasacort AQ
• Tri-Nasal

In Canada

• Nasacort Aq
• Nasacort Cfc-Free

Available Dosage Forms:

• Spray
• Aerosol Powder

Therapeutic Class: Anti-Inflammatory

Pharmacologic Class: Triamcinolone

• Tell all of your health care providers that you take triamcinolone. This includes your doctors, nurses, pharmacists, and dentists.
• This medicine may raise the chance of cataracts or glaucoma. Talk with the doctor.
• Talk with your doctor if you come into contact with anyone who has chickenpox or measles and you have not had chickenpox, measles, or the vaccines for them.
• If you have had any recent nose surgery, injury, ulcers, or sores, talk with your doctor.
• This medicine may affect growth in children and teens in some cases. They may need regular growth checks. Talk with the doctor.
• Use with care in children. Talk with the doctor.
• Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this medicine while you are pregnant.
• Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.

If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened.

• If your symptoms or health problems do not get better or if they become worse, call your doctor.
• Do not share your drugs with others and do not take anyone else's drugs.
• Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.
• Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.
• Some drugs may have another patient information leaflet. Check with your pharmacist. If you have any questions about this medicine, please talk with your doctor, nurse, pharmacist, or other health care provider.
• If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened.

This information should not be used to decide whether or not to take triamcinolone or any other medicine. Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this medicine. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to triamcinolone. This information is not specific medical advice and does not replace information you receive from the healthcare provider. You must talk with the healthcare provider for complete information about the risks and benefits of using this medicine.

Review Date: October 4, 2017

• Triamcinolone Acetonide

Controls the rate of protein synthesis, depresses the migration of polymorphonuclear leukocytes and fibroblasts, reverses capillary permeability, and stabilizes lysosomal membranes at the cellular level to prevent or control inflammation

Absorption

Systemic absorption may occur following intranasal administration.

Excretion

Urine (~40%); feces (~60%)

Half-Life Elimination

Biologic: 18-36 hours; Terminal (intranasal): 3.1 hours

Allergic rhinitis/upper respiratory symptoms: Intranasal: Two sprays (110 mcg) in each nostril once daily; once symptoms controlled reduce to 1 spray (55 mcg) in each nostril once daily (maximum: 2 sprays [110 mcg] in each nostril once daily). Discontinue therapy if adequate symptomatic relief is not observed within 3 weeks (1 week for OTC use).

Allergic rhinitis/upper respiratory symptoms: Intranasal: Note: Discontinue therapy if adequate symptomatic relief is not observed within 3 weeks (1 week for OTC use).

Children 2 to <6 years: One spray (55 mcg) in each nostril once daily (maximum: 1 spray [55 mcg] in each nostril once daily

Children 6 to <12 years: Initial: One spray (55 mcg) in each nostril once daily; may increase to 2 sprays (110 mcg) in each nostril once daily if response not adequate; once symptoms controlled may reduce to 1 spray (55 mcg) in each nostril once daily (maximum: 2 sprays [110 mcg] in each nostril once daily)

Children ≥12 years and Adolescents: Refer to adult dosing.

There are no dosage adjustments provided in the manufacturer’s labeling (has not been studied).

Shake well prior to use. Gently blow nose to clear nostrils. Avoid spraying into mouth or eyes and do not blow nose for 15 minutes after use. Prime prior to first use by shaking contents well and releasing 5 sprays into the air. If product is not used for more than 2 weeks, reprime with 1 spray. Consider use of a nasal vasoconstrictor for 2 to 3 days before initiating therapy in patients with excessive nasal mucous secretion or nasal mucosa edema.